The discovery and clinical development of RPR 106541: an airway-selective steroid for the treatment of asthma

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.5, Iss.2, 2000-07, pp. : 231-239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective airway responsiveness in asthma

By O'Connor B.J. Crowther S.D. Costello J.F. Morley J.

Trends in Pharmacological Sciences, Vol. 20, Iss. 1, 1999-01 ,pp. : 9-11

Elsevier

Access to resources Recommend Favorite

The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice

Current Clinical Pharmacology, Vol. 8, Iss. 2, 2013-01 ,pp. : 135-155

Bentham Science Publishers

Access to resources Recommend Favorite

Antileukotrienes in clinical development for asthma

By Santus Pierachille Centanni Stefano

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 1, 2002-01 ,pp. : 49-58

Informa Healthcare

Access to resources Recommend Favorite

Targeting Airway Inflammation: Novel Therapies for the Treatment of Asthma

Current Medicinal Chemistry, Vol. 13, Iss. 25, 2006-10 ,pp. : 3105-3111

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence

By Sacco Emilio Bientinesi Riccardo Tienforti Daniele Racioppi Marco Gulino Gaetano D'Agostino Daniele Vittori Matteo Bassi Pierfrancesco

Expert Opinion on Drug Discovery, Vol. 9, Iss. 4, 2014-04 ,pp. : 433-448

Informa Healthcare

Access to resources Recommend Favorite